Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase I first-in-man trial of ZP 2929 in volunteers.

Trial Profile

Phase I first-in-man trial of ZP 2929 in volunteers.

Phase of Trial: Phase I

Latest Information Update: 13 Sep 2012

At a glance

  • Drugs ZP 2929 (Primary)
  • Indications Obesity; Type 2 diabetes mellitus
  • Focus Adverse reactions
  • Most Recent Events

    • 13 Sep 2012 Status changed from planning to recruiting, as reported in a Zealand Pharma media release (the first patient has been dosed).
    • 27 Aug 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top